Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing.
Ana Belen AraúzDiego H CáceresErika SantiagoPaige ArmstrongSusan ArosemenaCarolina RamosAndres Espinosa-BodeJovanna BoraceLizbeth HayerIsrael CedeñoBrendan R JacksonNestor SosaElizabeth L BerkowShawn R LockhartAmalia Rodriguez-FrenchTom ChillerPublished in: Mycoses (2017)
Candida auris is an emerging multidrug-resistant (MDR) fungus associated with invasive infections and high mortality. This report describes 9 patients from whom C. auris was isolated at a hospital in Panama City, Panama, the first such cases in Central America, and highlights the challenges of accurate identification and methods for susceptibility testing.
Keyphrases
- multidrug resistant
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- healthcare
- high resolution
- emergency department
- candida albicans
- cardiovascular disease
- patient reported outcomes
- escherichia coli
- coronary artery disease
- cardiovascular events
- mass spectrometry
- cystic fibrosis
- gram negative
- klebsiella pneumoniae
- adverse drug
- acute care